Onconetix, Inc. Shares Outstanding (Cover Page)
Onconetix, Inc. (ONCO) had Shares Outstanding (Cover Page) of 3.95 million shares as of 2026-08-13, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-13: Entity Common Stock, Shares Outstanding 3.95M shares.
- 2026-05-12: Entity Common Stock, Shares Outstanding 11.46M shares.
- 2026-03-11: Entity Common Stock, Shares Outstanding 3.58M shares.
- 2025-11-12: Entity Common Stock, Shares Outstanding 1.56M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-13 | 3.95M shares 10-Q · filed 2026-08-13 |
| 2026-05-12 | 11.46M shares 10-Q · filed 2026-05-13 |
| 2026-03-11 | 3.58M shares 10-K · filed 2026-03-13 |
| 2025-11-12 | 1.56M shares 10-Q · filed 2025-11-13 |
| 2025-08-13 | 1.55M shares 10-Q · filed 2025-08-14 |
| 2025-06-12 | 44.36M shares 10-Q · filed 2025-06-12 |
| 2025-05-30 | 44.36M shares 10-K · filed 2025-06-02 |
| 2024-12-05 | 8.29M shares 10-Q · filed 2024-12-10 |
| 2024-08-29 | 29.79M shares 10-Q · filed 2024-08-29 |
| 2024-05-20 | 22.33M shares 10-Q · filed 2024-05-20 |
| 2024-04-11 | 22.33M shares 10-K · filed 2024-04-11 |
| 2023-11-17 | 18.66M shares 10-Q · filed 2023-11-17 |
| 2023-10-20 | 17.99M shares 10-Q · filed 2023-10-20 |
| 2023-05-12 | 15.91M shares 10-Q · filed 2023-05-12 |
| 2023-03-06 | 15.91M shares 10-K · filed 2023-03-09 |
| 2022-11-14 | 15.47M shares 10-Q · filed 2022-11-14 |
| 2022-08-15 | 13.58M shares 10-Q · filed 2022-08-15 |
| 2022-05-12 | 11.64M shares 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |